| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 81, 1784-1791, Copyright © 1990 by American Heart Association
T Aoyama, Y Yui, H Morishita and C Kawai
To investigate the prostaglandin I2 (PGI2) half-life regulated by high
density lipoprotein (HDL) in patients with coronary artery disease (CAD),
we determined the stability of PGI2 and serum apolipoprotein A-I (Apo A-I)
and apolipoprotein A-II (Apo A-II) levels in four age-matched groups of
patients: controls (n = 17), angina pectoris (n = 18), unstable angina
pectoris (n = 17), myocardial infarction (n = 19) (acute phase, 3.6 +/- 1.7
hours from onset; subacute phase, 75 +/- 15 hours from onset in the same
patients). Serum PGI2 half-life and total serum Apo A-I levels were lower
in the CAD group than in the control group. PGI2 was least stable in
patients with unstable angina and the acute phase of myocardial infarction.
In these patients, the molar ratio of Apo A-I to Apo A-II and
HDL-associated Apo A-I levels were decreased, and free Apo A-I levels were
increased. After in vitro incubation of HDL with increasing amounts of Apo
A-II, Apo A-I in HDL was displaced by Apo A-II, with the parallel decrease
in stability of PGI2. Free Apo A-I cannot stabilize PGI2. HDL-associated
Apo A-I, whose amount is affected by Apo A-II, stabilized PGI2 and
correlated well with stability of PGI2 in patients with CAD and control
patients. Decreased PGI2 half-life may play an important role in the
pathogenesis of atherosclerosis and thrombus formation in the coronary
arteries, especially thrombus formation during an acute coronary event.
ARTICLES
Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris
Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
This article has been cited by other articles:
![]() |
L. Calabresi, G. Rossoni, M. Gomaraschi, F. Sisto, F. Berti, and G. Franceschini High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-{alpha} Content and Enhancing Prostaglandin Release Circ. Res., February 21, 2003; 92(3): 330 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miwa, N. Yoshida, K. Nakagawa, and H. Inoue High-density lipoprotein particles are large in patients with variant angina Cardiovasc Res, March 1, 1998; 37(3): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Rosenson Beyond Low-Density Lipoprotein Cholesterol: A Perspective on Low High-Density Lipoprotein Disorders and Lp(a) Lipoprotein Excess Arch Intern Med, June 24, 1996; 156(12): 1278 - 1284. [Abstract] [PDF] |
||||
![]() |
M. R. Soma, E. Donetti, C. Parolini, C. R. Sirtori, R. Fumagalli, and G. Franceschini Recombinant Apolipoprotein A-IMilano Dimer Inhibits Carotid Intimal Thickening Induced by Perivascular Manipulation in Rabbits Circ. Res., March 1, 1995; 76(3): 405 - 411. [Abstract] [Full Text] |
||||
![]() |
R. S. Rosenson Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia) An Approach to Management Arch Intern Med, July 12, 1993; 153(13): 1528 - 1538. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |